Other

Drugmaker GSK buys US vaccine firm for up to $3.3 bn

British drugmaker GlaxoSmithKline on Tuesday snapped up US biopharmaceutical firm Affinivax for up to $3.3 billion, expanding further into vaccines before the demerger of its consumer health care arm.

Other

Pfizer to exit GSK joint venture after demerger

US drugs giant Pfizer will exit its consumer healthcare joint venture with GlaxoSmithKline after the unit is spun off next month, the British drugmaker said Wednesday.

Medications

British drugs firm GSK settles US drug disputes for $3.0 bln

GlaxoSmithKline said on Thursday it had agreed to pay $3.0 billion (2.2 billion euros) to settle long-running disputes with the US government over how the British pharmaceuticals group marketed and developed drugs.

Medications

Drug firm GSK fined $2.6 million for collusion

South Korea's anti-trust agency has fined drugmaker GlaxoSmithKline three billion won ($2.6 million) for conspiring with a Seoul rival over the sale of drugs, an official said Monday.

Vaccination

Medicago and GSK to begin final Covid-19 vaccine trials

Canada's Medicago and British pharmaceutical giant GlaxoSmithKline (GSK) announced Thursday the launch of phase 2 and 3 clinical trials on a COVID-19 vaccine, one of a series of candidates being developed worldwide.

Oncology & Cancer

Combination therapy overcomes BET inhibitor resistance, shows study

Scientists at St. Jude Children's Research Hospital developed a novel combination therapy approach for a leukemia subtype harboring rearrangements in the KMT2A gene. The approach overcomes the cancer's drug resistance, without ...

Vaccination

Sanofi-GSK COVID booster jab shows positive results

French drug maker Sanofi said Monday a COVID booster shot it is developing with Britain's GlaxoSmithKline has produced positive results against Omicron and other variants in clinical trials.

Other

Drugmaker settles US Zantac cancer case

British pharmaceutical group GlaxoSmithKline said Friday it has settled a US lawsuit which had alleged heartburn drug Zantac caused cancer, but admitted no liability.

page 2 from 7